Personalis, Inc. (PSNL)
6.725
+0.06
(+0.98%)
USD |
NASDAQ |
Apr 17, 16:00
6.725
0.00 (0.00%)
After-Hours: 17:56
Personalis EPS Diluted (Quarterly) : -0.258 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -0.8263 |
| Celldex Therapeutics, Inc. | -1.223 |
| Plus Therapeutics, Inc. | -1.03 |
| Atossa Therapeutics, Inc. | -1.270 |
| Abeona Therapeutics, Inc. | -0.3717 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.81M |
| Revenue (Quarterly) | 17.34M |
| Total Expenses (Quarterly) | 41.16M |
| Enterprise Value | 497.70M |
| Gross Profit Margin (Quarterly) | 10.95% |
| Profit Margin (Quarterly) | -137.3% |
| Earnings Yield | -13.51% |
| Normalized Earnings Yield | -13.51 |